Predictors of Exposure Success in Public Speaking Anxiety
NCT ID: NCT02163148
Last Updated: 2015-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2014-05-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Social Phobia
NCT00000370
Optimizing Exposure Therapy Via Reward-focused Interventions in Individuals With Public Speaking Anxiety
NCT06258889
Group Exposure Workshops for Socially Anxious Undergraduates
NCT06673407
Reward Processing and Exposure Therapy for Social Anxiety Disorder
NCT06776991
An Online Large-group One-session Treatment for Public Speaking Anxiety
NCT04790864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Public Speaking Anxiety
Intervention to be administered: One speech exposure session.
Massed speech exposure session
One session consisting of 4 speech exposures, each 5 minutes long.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Massed speech exposure session
One session consisting of 4 speech exposures, each 5 minutes long.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-55
* English fluency
Exclusion Criteria
* Past experience with exposure based therapy
* History of bipolar disorder, psychotic disorder, or substance dependence
* Current major depressive disorder of greater than moderate severity (defined as a score on the 9 item Patient Health Questionnaire of greater than 14)
* Clinically significant suicidal or homicidal ideation
* Non-removable ferrous metal
* Current significant neurological conditions
* History of loss of consciousness greater than 5 minutes duration
* Pregnant
* Claustrophobic
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tali Manber Ball
Doctoral Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tali M Ball, MA
Role: PRINCIPAL_INVESTIGATOR
UCSD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSD Psychiatry Research
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ball TM, Knapp SE, Paulus MP, Stein MB. Brain activation during fear extinction predicts exposure success. Depress Anxiety. 2017 Mar;34(3):257-266. doi: 10.1002/da.22583. Epub 2016 Dec 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCSDIRB-130313
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.